NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $4.99 payment

Prepare rigorously for the NAPLEX, the pivotal examination for pharmacy licensure! Gain confidence with expertly crafted quizzes and study materials tailored for aspiring pharmacists. Elevate your understanding and skills today!

Practice this question and more.


Quinupristin/Dalfopristin is approved for the treatment of?

  1. Hepatic encephalopathy

  2. Complicated skin and soft-tissue infections (SSTI)

  3. Bloodstream infections

  4. Common cold

The correct answer is: Complicated skin and soft-tissue infections (SSTI)

Quinupristin/Dalfopristin, also known as Synercid, is a combination antibiotic that is used specifically for the treatment of complicated skin and soft-tissue infections (SSTI). These types of infections are often caused by drug-resistant bacteria and require a strong and targeted antibiotic like Quinupristin/Dalfopristin. This medication is not approved for the treatment of hepatic encephalopathy, bloodstream infections, or the common cold. Therefore, options A, C, and D are incorrect.